Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2939294rdf:typepubmed:Citationlld:pubmed
pubmed-article:2939294lifeskim:mentionsumls-concept:C0038317lld:lifeskim
pubmed-article:2939294lifeskim:mentionsumls-concept:C1512505lld:lifeskim
pubmed-article:2939294lifeskim:mentionsumls-concept:C0040845lld:lifeskim
pubmed-article:2939294lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:2939294pubmed:issue1lld:pubmed
pubmed-article:2939294pubmed:dateCreated1986-6-12lld:pubmed
pubmed-article:2939294pubmed:abstractTextMembrane binding sites for peanut lectin or peanut agglutinin (PNA) were investigated in the established mammary carcinoma cell lines MCF-7, 734-B, ZR-75.1 and BT-20. The determination of PNA binding sites was performed in a flow cytometer after staining with fluorescein(FITC)-labeled PNA. It appeared that only the estrogen-sensitive cell lines exhibited PNA binding sites, whereas the hormone-insensitive cell line BT-20 was clearly negative. Steroid hormones, when administered singly to the cells in physiological concentrations (10(-9)-10(-8) M) had no effect on PNA binding expression. Only the combination of estradiol and progesterone together increased PNA binding sites. Pharmacological doses (10(-6) M) of medroxyprogesteroneacetate (MPA) and dexamethasone increased the number of binding sites, whereas retinoic acid decreased them. A preliminary characterization of the binding sites revealed that they have high capacity and moderate affinity for PNA (KD greater than 10(-7) M). FITC-PNA binding could be inhibited selectively by fetuin (greater than 10(-5) M) and by galactose (greater than 10(-2) M). Cytosol from MCF-7 cells and from some primary breast cancer specimens were able to decrease PNA binding to the surface of 734-B cells.lld:pubmed
pubmed-article:2939294pubmed:languageenglld:pubmed
pubmed-article:2939294pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:citationSubsetIMlld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939294pubmed:statusMEDLINElld:pubmed
pubmed-article:2939294pubmed:monthJanlld:pubmed
pubmed-article:2939294pubmed:issn0022-4731lld:pubmed
pubmed-article:2939294pubmed:authorpubmed-author:DapuntOOlld:pubmed
pubmed-article:2939294pubmed:authorpubmed-author:BöckGGlld:pubmed
pubmed-article:2939294pubmed:authorpubmed-author:DaxenbichlerG...lld:pubmed
pubmed-article:2939294pubmed:authorpubmed-author:MartiBBlld:pubmed
pubmed-article:2939294pubmed:authorpubmed-author:DürkenMMlld:pubmed
pubmed-article:2939294pubmed:issnTypePrintlld:pubmed
pubmed-article:2939294pubmed:volume24lld:pubmed
pubmed-article:2939294pubmed:ownerNLMlld:pubmed
pubmed-article:2939294pubmed:authorsCompleteYlld:pubmed
pubmed-article:2939294pubmed:pagination119-24lld:pubmed
pubmed-article:2939294pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:meshHeadingpubmed-meshheading:2939294-...lld:pubmed
pubmed-article:2939294pubmed:year1986lld:pubmed
pubmed-article:2939294pubmed:articleTitleInfluence of steroids and retinoic acid on peanut-lectin binding of human breast cancer cells.lld:pubmed
pubmed-article:2939294pubmed:publicationTypeJournal Articlelld:pubmed